Literature DB >> 33440237

Mini-Review: Is iron-mediated cell death (ferroptosis) an identical factor contributing to the pathogenesis of some neurodegenerative diseases?

Alena Viktorinova1, Monika Durfinova2.   

Abstract

The review article briefly discusses a hypothesis based on the potential participation of iron dyshomeostasis and iron-mediated cell death (ferroptosis) in the pathogenesis of some neurodegenerative diseases. Iron dyshomeostasis (especially cellular iron overload) is considered to be a critical condition of neurodegeneration. The etiopathogenesis of many neurodegenerative diseases including Alzheimer's and Parkinson's diseases, Multiple sclerosis, and others, is different. However, there are several identical cellular processes, such as iron dyshomeostasis (an excessive iron deposition), iron-induced oxidative stress, the accumulation of lipid-generated reactive oxygen species, and ferroptosis that accompany these diseases. Based on the existing theoretical and experimental evidence, the article provides current insight into iron dyshomeostasis and ferroptosis as a contributing factor to the pathogenesis of neurodegeneration. In addition, special attention is addressed to the possible relationship between cellular iron overload and key pathological features of selected neurodegenerative diseases, such as β-amyloid and tau proteins, α-synuclein, and demyelination. The mechanism by which ferroptosis may be involved in the pathogenesis of various neurodegenerative diseases is not fully elucidated. Further experimental and clinical studies are needed to clarify the hypothesis on the potential role of ferroptosis in the pathogenesis of neurodegenerative diseases.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Demyelination; Ferroptosis; Iron dyshomeostasis; Lipid peroxidation; Neurodegeneration

Mesh:

Substances:

Year:  2021        PMID: 33440237     DOI: 10.1016/j.neulet.2021.135627

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Higher R2* in the Red Nucleus Is Associated With Lead Exposure in an Asymptomatic Welder Cohort.

Authors:  Janina Manzieri Prado-Rico; Eun-Young Lee; Ernest W Wang; Jeff D Yanosky; Lan Kong; Hairong Chen; Ana Navas-Acien; Guangwei Du; Mechelle M Lewis; Richard B Mailman; Xuemei Huang
Journal:  Toxicol Sci       Date:  2022-05-26       Impact factor: 4.109

Review 2.  Ferroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization?

Authors:  Jia-Yue Duan; Xiao Lin; Feng Xu; Su-Kang Shan; Bei Guo; Fu-Xing-Zi Li; Yi Wang; Ming-Hui Zheng; Qiu-Shuang Xu; Li-Min Lei; Wen-Lu Ou-Yang; Yun-Yun Wu; Ke-Xin Tang; Ling-Qing Yuan
Journal:  Front Cell Dev Biol       Date:  2021-07-09

Review 3.  Emerging Pathological Engagement of Ferroptosis in Gut Diseases.

Authors:  Weihua Gao; Ting Zhang; Hao Wu
Journal:  Oxid Med Cell Longev       Date:  2021-10-25       Impact factor: 6.543

Review 4.  A Peek into Pandora's Box: COVID-19 and Neurodegeneration.

Authors:  Abhishek Chandra; Ashu Johri
Journal:  Brain Sci       Date:  2022-01-30

5.  Screening of Differentially Expressed Iron Death-Related Genes and the Construction of Prognosis Model in Patients with Renal Clear Cell Carcinoma.

Authors:  Ding Wu; Zhenyu Xu; Zhan Shi; Ping Li; Huichen Lv; Jie Huang; Dian Fu
Journal:  Comput Math Methods Med       Date:  2022-08-30       Impact factor: 2.809

6.  Therapeutic potential of deuterium-stabilized (R)-pioglitazone-PXL065-for X-linked adrenoleukodystrophy.

Authors:  Pierre-Axel Monternier; Jaspreet Singh; Parveen Parasar; Pierre Theurey; Sheila DeWitt; Vincent Jacques; Eric Klett; Navtej Kaur; Tavarekere N Nagaraja; David E Moller; Sophie Hallakou-Bozec
Journal:  J Inherit Metab Dis       Date:  2022-05-19       Impact factor: 4.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.